REPORT ID 13762

Global Progesterone Sales Market Report 2017

Publish Date
22-Nov-17
Pages
119
Format
Electronic (PDF)

In this report, the global Progesterone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Progesterone for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Progesterone market competition by top manufacturers/players, with Progesterone sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Merck Serono
    Solvay
    Glaxosmithkline
    Sanofi Aventis
    Actavis
    Xianju Pharma
    Asen
    Chenggu Zhenhua Bio-Tech
    Kaitai Hormone
    Zhejiang Medicine Xinchang
    Hongyuan Pharmaceutical
    Senzu
    Hubei Fangtong Pharmaceutical
    Kaitai Hormone
    Xian Gaoyuan
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Prevention of Preterm Birth
    Gynecological Disorders
    Other Uses
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Liauid
    Tablets

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Progesterone Sales Market Report 2017
1 Progesterone Market Overview
    1.1 Product Overview and Scope of Progesterone
    1.2 Classification of Progesterone by Product Category
        1.2.1 Global Progesterone Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Progesterone Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Prevention of Preterm Birth
        1.2.4 Gynecological Disorders
        1.2.5 Other Uses
    1.3 Global Progesterone Market by Application/End Users
        1.3.1 Global Progesterone Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Liauid
        1.3.3 Tablets
    1.4 Global Progesterone Market by Region
        1.4.1 Global Progesterone Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Progesterone Status and Prospect (2012-2022)
        1.4.3 China Progesterone Status and Prospect (2012-2022)
        1.4.4 Europe Progesterone Status and Prospect (2012-2022)
        1.4.5 Japan Progesterone Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Progesterone Status and Prospect (2012-2022)
        1.4.7 India Progesterone Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Progesterone (2012-2022)
        1.5.1 Global Progesterone Sales and Growth Rate (2012-2022)
        1.5.2 Global Progesterone Revenue and Growth Rate (2012-2022)

2 Global Progesterone Competition by Players/Suppliers, Type and Application
     2.1 Global Progesterone Market Competition by Players/Suppliers
        2.1.1 Global Progesterone Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Progesterone Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Progesterone (Volume and Value) by Type
        2.2.1 Global Progesterone Sales and Market Share by Type (2012-2017)
        2.2.2 Global Progesterone Revenue and Market Share by Type (2012-2017)
    2.3 Global Progesterone (Volume and Value) by Region
        2.3.1 Global Progesterone Sales and Market Share by Region (2012-2017)
        2.3.2 Global Progesterone Revenue and Market Share by Region (2012-2017)
    2.4 Global Progesterone (Volume) by Application

3 United States Progesterone (Volume, Value and Sales Price)
    3.1 United States Progesterone Sales and Value (2012-2017)
        3.1.1 United States Progesterone Sales and Growth Rate (2012-2017)
        3.1.2 United States Progesterone Revenue and Growth Rate (2012-2017)
        3.1.3 United States Progesterone Sales Price Trend (2012-2017)
    3.2 United States Progesterone Sales Volume and Market Share by Players
    3.3 United States Progesterone Sales Volume and Market Share by Type
    3.4 United States Progesterone Sales Volume and Market Share by Application

4 China Progesterone (Volume, Value and Sales Price)
    4.1 China Progesterone Sales and Value (2012-2017)
        4.1.1 China Progesterone Sales and Growth Rate (2012-2017)
        4.1.2 China Progesterone Revenue and Growth Rate (2012-2017)
        4.1.3 China Progesterone Sales Price Trend (2012-2017)
    4.2 China Progesterone Sales Volume and Market Share by Players
    4.3 China Progesterone Sales Volume and Market Share by Type
    4.4 China Progesterone Sales Volume and Market Share by Application

5 Europe Progesterone (Volume, Value and Sales Price)
    5.1 Europe Progesterone Sales and Value (2012-2017)
        5.1.1 Europe Progesterone Sales and Growth Rate (2012-2017)
        5.1.2 Europe Progesterone Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Progesterone Sales Price Trend (2012-2017)
    5.2 Europe Progesterone Sales Volume and Market Share by Players
    5.3 Europe Progesterone Sales Volume and Market Share by Type
    5.4 Europe Progesterone Sales Volume and Market Share by Application

6 Japan Progesterone (Volume, Value and Sales Price)
    6.1 Japan Progesterone Sales and Value (2012-2017)
        6.1.1 Japan Progesterone Sales and Growth Rate (2012-2017)
        6.1.2 Japan Progesterone Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Progesterone Sales Price Trend (2012-2017)
    6.2 Japan Progesterone Sales Volume and Market Share by Players
    6.3 Japan Progesterone Sales Volume and Market Share by Type
    6.4 Japan Progesterone Sales Volume and Market Share by Application

7 Southeast Asia Progesterone (Volume, Value and Sales Price)
    7.1 Southeast Asia Progesterone Sales and Value (2012-2017)
        7.1.1 Southeast Asia Progesterone Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Progesterone Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Progesterone Sales Price Trend (2012-2017)
    7.2 Southeast Asia Progesterone Sales Volume and Market Share by Players
    7.3 Southeast Asia Progesterone Sales Volume and Market Share by Type
    7.4 Southeast Asia Progesterone Sales Volume and Market Share by Application

8 India Progesterone (Volume, Value and Sales Price)
    8.1 India Progesterone Sales and Value (2012-2017)
        8.1.1 India Progesterone Sales and Growth Rate (2012-2017)
        8.1.2 India Progesterone Revenue and Growth Rate (2012-2017)
        8.1.3 India Progesterone Sales Price Trend (2012-2017)
    8.2 India Progesterone Sales Volume and Market Share by Players
    8.3 India Progesterone Sales Volume and Market Share by Type
    8.4 India Progesterone Sales Volume and Market Share by Application

9 Global Progesterone Players/Suppliers Profiles and Sales Data
    9.1 Pfizer
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Progesterone Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Pfizer Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 Merck Serono
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Progesterone Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Merck Serono Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Solvay
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Progesterone Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Solvay Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Glaxosmithkline
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Progesterone Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Glaxosmithkline Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Sanofi Aventis
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Progesterone Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Sanofi Aventis Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Actavis
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Progesterone Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Actavis Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Xianju Pharma
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Progesterone Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Xianju Pharma Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Asen
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Progesterone Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Asen Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Chenggu Zhenhua Bio-Tech
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Progesterone Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Chenggu Zhenhua Bio-Tech Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview
    9.10 Kaitai Hormone
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Progesterone Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Kaitai Hormone Progesterone Sales, Revenue, Price and Gross Margin (2012-2017)
        9.10.4 Main Business/Business Overview
    9.11 Zhejiang Medicine Xinchang
    9.12 Hongyuan Pharmaceutical
    9.13 Senzu
    9.14 Hubei Fangtong Pharmaceutical
    9.15 Kaitai Hormone
    9.16 Xian Gaoyuan

10 Progesterone Maufacturing Cost Analysis
    10.1 Progesterone Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Progesterone
    10.3 Manufacturing Process Analysis of Progesterone

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Progesterone Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Progesterone Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Progesterone Market Forecast (2017-2022)
    14.1 Global Progesterone Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Progesterone Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Progesterone Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Progesterone Price and Trend Forecast (2017-2022)
    14.2 Global Progesterone Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Progesterone Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Progesterone Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Progesterone Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Progesterone Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Progesterone Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Progesterone Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Progesterone Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Progesterone Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Progesterone Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Progesterone Sales Forecast by Type (2017-2022)
       14.3.2 Global Progesterone Revenue Forecast by Type (2017-2022)
       14.3.3 Global Progesterone Price Forecast by Type (2017-2022)
    14.4 Global Progesterone Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer